Advanced Practice Providers (APPs) have a key role in the management of pediatric cancer and blood disorders. APPs require ongoing education in the specific areas of diagnosis, management, and procedures. Requested educational updates include management of oncology-specific dermatology complications; management of acute upper respiratory illness in the setting of immunosuppression; neurologic exam and pertinent associated findings; endocrinologic complications in the patient with cancer; thrombosis and management of central line associated clots; oncologic emergencies; and procedural practice of bone marrow aspirations, biopsies, and lumbar punctures.
Learners will be engaged through case studies, discussion, and simulation. Cooperative learning groups will be used to split attendees into subspecialties of hematology, oncology, and bone marrow transplant. Within each subspecialty, group discussion will provide time for reflection and problem-based learning as attendees present challenging cases and utilize the group for problem-solving. As a result of attending this pre-conference session, APPs will be better equipped to manage minor acute illnesses and routine complications in the Hem/Onc/BMT patient. The identified learner gap of holistic care for the acute and chronically ill patient with cancer or blood disorders will be addressed. APPs’ knowledge will be expanded with hands-on, concrete education utilized in the day-to-day care for our specific population. APPs will also gain peers and colleagues with whom to network for future collaboration.
- Creating a Pediatric Hematology/Oncology Manuscript to Submit for Publication in a Nursing Journal (003)
- Opening Keynote: Never Ever Give Up! (101)
- General Session: Oral Medicine for Pediatric Hematology/Oncology Nursing (102)
- It's All GREEK To Me! The NEPENTHE Trial for Relapsed/Refractory Neuroblastoma; Personalized Molecularly Targeted Treatment (200)
- A Sustainable Community Engagement Program Model to Address Hematopoietic Cell Transplantation Education Needs for Patients with Sickle Cell Disease (201)